For the first time, fetuses in the womb with brittle bone disease will be treated with stem cells.
The goal is that the cells, which can work in many tissues, will
alleviate the symptoms of brittle bone disease, which is incurable.
The rare condition — which affects 1 in every 25,000 births — results
from a genetic mutation and causes severe pain and broken bones.
Those afflicted often have additional medical ailments,
